Gene Review:
CNBP - CCHC-type zinc finger, nucleic acid...
Homo sapiens
Synonyms:
CNBP1, Cellular nucleic acid-binding protein, DM2, PROMM, RNF163, ...
Ricker,
Benzow,
Shimada,
Gaul,
Rasmussen,
Mueller-Myhsok,
Toyka,
Yamada,
Kress,
Köstler,
Hahn,
Mori,
Sandstede,
Koob,
Ishimaru,
Reimers,
Schulte-Mattler,
Schneider,
Toyka,
Moriuchi,
Debska-Vielhaber,
Schneider-Gold,
Heinze,
Niessen,
Buchner,
Vielhaber,
Jakubiczka,
Mueller,
Kaufmann,
Beer,
Day,
Koch,
Katamine,
Ranum,
Schoenfeld,
Grimm,
Finsterer,
Ranum,
Day,
Zierz,
- Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W., Ranum, L.P. Science (2001)
- Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Liquori, C.L., Ikeda, Y., Weatherspoon, M., Ricker, K., Schoser, B.G., Dalton, J.C., Day, J.W., Ranum, L.P. Am. J. Hum. Genet. (2003)
- Linkage of proximal myotonic myopathy to chromosome 3q. Ricker, K., Grimm, T., Koch, M.C., Schneider, C., Kress, W., Reimers, C.D., Schulte-Mattler, W., Mueller-Myhsok, B., Toyka, K.V., Mueller, C.R. Neurology (1999)
- Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein. McGrath, C.F., Buckman, J.S., Gagliardi, T.D., Bosche, W.J., Coren, L.V., Gorelick, R.J. J. Virol. (2003)
- The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Gerbasi, V.R., Link, A.J. Mol. Cell Proteomics (2007)
- A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Le Ber, I., Martinez, M., Campion, D., Laquerrière, A., Bétard, C., Bassez, G., Girard, C., Saugier-Veber, P., Raux, G., Sergeant, N., Magnier, P., Maisonobe, T., Eymard, B., Duyckaerts, C., Delacourte, A., Frebourg, T., Hannequin, D. Brain (2004)
- Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Sansone, V., Gandossini, S., Cotelli, M., Calabria, M., Zanetti, O., Meola, G. Neurol. Sci. (2007)
- Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. Biessels, G.J., De Leeuw, F.E., Lindeboom, J., Barkhof, F., Scheltens, P. J. Neurol. Neurosurg. Psychiatr. (2006)
- Genetic mapping of a second myotonic dystrophy locus. Ranum, L.P., Rasmussen, P.F., Benzow, K.A., Koob, M.D., Day, J.W. Nat. Genet. (1998)
- Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Bachinski, L.L., Udd, B., Meola, G., Sansone, V., Bassez, G., Eymard, B., Thornton, C.A., Moxley, R.T., Harper, P.S., Rogers, M.T., Jurkat-Rott, K., Lehmann-Horn, F., Wieser, T., Gamez, J., Navarro, C., Bottani, A., Kohler, A., Shriver, M.D., Sallinen, R., Wessman, M., Zhang, S., Wright, F.A., Krahe, R. Am. J. Hum. Genet. (2003)
- Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Merlini, L., Sabatelli, P., Columbaro, M., Bonifazi, E., Pisani, V., Massa, R., Novelli, G. Muscle Nerve (2005)
- Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1. Vielhaber, S., Jakubiczka, S., Gaul, C., Schoenfeld, M.A., Debska-Vielhaber, G., Zierz, S., Heinze, H.J., Niessen, H.G., Kaufmann, J. Muscle Nerve (2006)
- Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone. Ogawa, S., Takeuchi, K., Ito, S. J. Clin. Endocrinol. Metab. (2003)
- Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. van de Ree, M.A., Huisman, M.V., Princen, H.M., Meinders, A.E., Kluft, C. Atherosclerosis (2003)
- Myotonic dystrophy type 2. Finsterer, J. Eur. J. Neurol. (2002)
- Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population. Vallo, L., Bonifazi, E., Borgiani, P., Novelli, G., Botta, A. Mol. Cell. Probes (2005)
- Identification of NADH dehydrogenase 1 alpha subcomplex 5 capable to transform murine fibroblasts and overexpressed in human cervical carcinoma cell lines. Shimada, T., Moriuchi, R., Mori, T., Yamada, K., Ishimaru, T., Katamine, S. Biochem. Biophys. Res. Commun. (2006)
- Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Mankodi, A., Teng-Umnuay, P., Krym, M., Henderson, D., Swanson, M., Thornton, C.A. Ann. Neurol. (2003)
- Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Schneider-Gold, C., Beer, M., Köstler, H., Buchner, S., Sandstede, J., Hahn, D., Toyka, K.V. Muscle Nerve (2004)
- Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Meola, G., Sansone, V., Perani, D., Scarone, S., Cappa, S., Dragoni, C., Cattaneo, E., Cotelli, M., Gobbo, C., Fazio, F., Siciliano, G., Mancuso, M., Vitelli, E., Zhang, S., Krahe, R., Moxley, R.T. Neuromuscul. Disord. (2003)
- Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans. Stingl, H., Raffesberg, W., Nowotny, P., Waldhäusl, W., Roden, M. Obes. Res. (2002)
- Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease. Sahli, D., Eliasson, B., Svensson, M., Blohmé, G., Eliasson, M., Samuelsson, P., Ojbrandt, K., Eriksson, J.W. Angiology. (2004)
- Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene. Michelotti, E.F., Tomonaga, T., Krutzsch, H., Levens, D. J. Biol. Chem. (1995)
- Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Kino, Y., Mori, D., Oma, Y., Takeshita, Y., Sasagawa, N., Ishiura, S. Hum. Mol. Genet. (2004)
- An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental CLCN1 mutation. Lamont, P.J., Jacob, R.L., Mastaglia, F.L., Laing, N.G. J. Neurol. Neurosurg. Psychiatr. (2004)
- Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Cardani, R., Mancinelli, E., Rotondo, G., Sansone, V., Meola, G. European journal of histochemistry : EJH. (2006)
- Musculoskeletal pain in patients with myotonic dystrophy type 2. George, A., Schneider-Gold, C., Zier, S., Reiners, K., Sommer, C. Arch. Neurol. (2004)
- Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Botta, A., Caldarola, S., Vallo, L., Bonifazi, E., Fruci, D., Gullotta, F., Massa, R., Novelli, G., Loreni, F. Biochim. Biophys. Acta (2006)
- Myotonic dystrophy: RNA pathogenesis comes into focus. Ranum, L.P., Day, J.W. Am. J. Hum. Genet. (2004)